Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

No reported Investing Cash Flow figures are available to summarize.

Investing Cash Flow history

Currency unavailable · from the cash flow

No Investing Cash Flow data reported for this period type.

Investing Cash Flow vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Investing Cash Flow for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$293.7M USD+578.5%+656.7%—
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$170.56M USD+59.1%+228.6%852.8%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$124.43M USD+0.7%——
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$71.19M USD+59.3%+23.9%32.7%
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$57.94M USD-8.8%——
GHRSGH Research PLCLTM Mar 2026$43.35M USD-36.4%——
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$42.41M USD———
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+29.9%+228.6%442.8%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.